* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download PowerPoint Template
Survey
Document related concepts
Orphan drug wikipedia , lookup
Pharmaceutical marketing wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Theralizumab wikipedia , lookup
Compounding wikipedia , lookup
Neuropharmacology wikipedia , lookup
Drug design wikipedia , lookup
Prescription costs wikipedia , lookup
Drug interaction wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Pharmacognosy wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Transcript
Pre-formulation Dr. Zahra Hesari Pharm D, PhD of Pharmaceutics Session 3 LOGO Guilan university of Medical Sciences, Faculty of Pharmacy Review potency Proteins Organic Salts (Dose) Membrane permeability Solid dosage form excipients Organic esters Hydrates & solvates LogP pKa Drug and Drug Product Stability • Drug samples of known purity • Stability studies in the preformulation phase: – Solid-state stability of the drug alone – Solution-phase stability – Stability in the presence of expected excipients Initial investigation: drug’s chemical structure Drug substances (Chemically): alcohols, phenols, aldehydes, ketones, esters, ethers, acids, salts, alkaloids, glycosides Drug Stability Mechanisms of Degradation • Most frequently chemical destructive processes – Hydrolysis – Oxidation • Hydrolysis – Drug molecules interact with water molecules to yield breakdown products – Great number of drugs are esters or contain such other groupings as substituted amides, lactones, and lactams • Oxidation – Aldehydes, alcohols, phenols, sugars, alkaloids, and unsaturated fats and oils – Loss of electron, increase in the positive valence, loss of hydrogen – Free chemical radicals – Autoxidations: (atmospheric oxygen- chain reaction) Kinetics and Shelf Life • Stability definition • Stability concern types: 1. 2. 3. 4. 5. • Chemical stability – – – • Chemical Physical Microbiologic Therapeutic Toxicologic Storage conditions Proper container Anticipating interactions when mixing drugs and dosage forms Stability and expiration dating are based on reaction kinetics Reaction kinetic Study of rate of chemical change This rate is influenced by concentration of reactants, products and solvent, pressure and temperature. Rate Reactions • Reaction rate is a description of the drug concentration with respect to time. • Most commonly in pharmacy – Zero-order reaction – First-order reactions Q10 Method of Shelf Life Estimation Estimate shelf life for a product that has been stored or is going to be stored under a different set of conditions Enhancing Stability of Drug Products • Incorporation of excipients – Increase the stability of the drug substance • Hydrolysis: • Hydrolysis & Oxidation reduction or elimination of water: waterproof protective coating over tablets keeping the drug in a tightly closed container substitute liquids such as glycerin, propylene glycol, and alcohol Anhydrous vegetable oil in injectable products Suspending in a nonaqueous vehicle rather than dissolving in an aqueous solvent Dry form for reconstitution (sp antibiotics) • • Refrigeration pH (5-6), buffering agents Enhancing Stability of Drug Products Oxidation • • Humidity in presence of oxygen or light Combination with other chemicals • • Alteration in the color, precipitation or a change in odor Antioxidants: providing electrons and hydrogen atoms Aqueous preparations: sodium sulfite (Na2SO3, at high pH) Oleaginous (oily or unctuous) sodium bisulfite (NaHSO3, at Preparations: intermediate pH) sodium metabisulfite (Na2S2O5, at low pH) • hypophosphorous acid (H3PO2) • ascorbic acid alpha-tocopherol, Butyl hydroxy anisole ascorbyl palmitate Sulfites • Preservative – – – Injectable drugs, such as antibiotics and local anesthetics inhalants and ophthalmic preparations few oral drugs • FDA labeling regulations – No generally suitable substitutes for sulfites 0.2% of the population who are subject to allergic reactions o Food products potassium bisulfite, potassium metabisulfite, sodium bisulfite, sodium metabisulfite, sodium sulfite, and sulfur dioxide. Antioxidant + other pharmaceutical additives Antioxidant + drug substance oxygen-free atmosphere during preparation and storage Oxidation • Trace metals – Purification of the source – Chelating agents: calcium disodium edetate and EDTA • Light (catalyst) – packaging in light-resistant or opaque containers • Temperature – Keep in cool place • pH – Most favorable for each preparation • Potassium Iodide Oral Solution, USP – Yellow to-brown discoloration – light-resistant containers – addition of 0.5 mg of sodium thiosulfate for each gram of KI. Formulation pharmacist may stabilize the preparation by the selective exclusion from the system of oxygen, oxidizing agents, trace metals, light, heat, and other chemical catalysts to the oxidation process. Antioxidants, chelating agents, and buffering agents may be added to create and maintain a favorable pH. Other less frequent destructive processes include polymerization, chemical decarboxylation, and deamination. Drug-Excipient Compatibility • Stress condition – Guideline of accelerated stability studies – Temp, pH, light, moisture, agitation, gravity, packaging, method of manufacture • Experimental studies: – Mixing drug with excipients – Aqueous suspension of Drug-Excipients – Factorial design • water addition: yes/no, • Temp: 25 or 40 ‘C • Time: 1 or 4 week – High temp & high humidity – Intact drug & degradation product are measured – Drug content, color, taste, related substances • Advanced analytical instrumentation – – – – Detect low levels of degradation products (less than 2%) Thermal analysis (DTA, DSC) Chromatographic methods (HPLC, LC/MS) Diffuse reflectance spectroscopy (DRS) Stability Testing • Pharmaceutical components and finished products • FDA’s GMP and ICH guideline: “Stability Testing of New Drug Substances and Products” “Quality of Biotechnological Products: Stability Testing of Biotechnology/Biological Drug Products” “Photostability Testing of New Drug Substances and Products” “Stability Testing of New Dosage Forms” Drug stability is important during preclinical testing and in clinical (human) trials For marketed drug product is vital during shelf life • Stability assessment before approval for marketing: – Influence of pharmaceutical ingredients – Influence of the container and closure – The manufacturing and processing conditions (e.g., heat) – Packaging components – Conditions of storage – Anticipated conditions of shipping, temperature, light, and humidity – Anticipated duration and conditions of pharmacy shelf life and patient use. In-process stability testing Packaging features Extemporaneous compounded formulations • USP guidelines on stability: 1. nonaqueous liquids and solid formulations in which the manufactured drug is the source of the active ingredient, not later than 25% of the time remaining until the product’s expiration date or 6 months, whichever is earlier. 2. nonaqueous liquids and solid formulations in which a USP or National Formulary (NF) substance is the source of active ingredient, a beyond-use date of 6 months. 3. watercontaining formulations prepared from ingredients in solid form, a beyond-use date not later than 14 days in storage at cold temperatures. 4. all other formulations, a beyond-use date of the intended duration of therapy or 30 days, whichever is earlier. LOGO Handout